Meropenem: clinical response in relation to in vitro susceptibility
Authors:
- H. LodeHLH. Lode
- J.R. EdwardsJEJ.R. Edwards
- 1 April 2000
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 6 (4) , 185-194
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Meropenem: evaluation of a new generation carbapenemInternational Journal of Antimicrobial Agents, 1997
- The Pharmacology of Meropenem, A New Carbapenem AntibioticClinical Infectious Diseases, 1997
- Comparative In Vitro Activity of Meropenem Versus Other Extended-Spectrum Antimicrobials Against Randomly Chosen and Selected Resistant Clinical Isolates Tested in 26 North American CentersClinical Infectious Diseases, 1997
- Meropenem: a microbiological overviewJournal of Antimicrobial Chemotherapy, 1995
- MeropenemDrugs, 1995
- Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by β-lactamasesJournal of Antimicrobial Chemotherapy, 1995
- Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolatesAntimicrobial Agents and Chemotherapy, 1990
- Meropenem: activity against resistant Gram-negative bacteria and interactions with -lactamasesJournal of Antimicrobial Chemotherapy, 1989
- Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum -lactamasesJournal of Antimicrobial Chemotherapy, 1989
- In-vitro studies of meropenemJournal of Antimicrobial Chemotherapy, 1989